Dilution of Share Value through the Exercise of Stock Options
First written in FY2018. 26 of 28 entries say "Materialised", first in FY2019-Q1. Latest entry: 2026-08-14.
eole moved to the "Worse" side of this theme in 2018, 2 years before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- FY2026WorsenedAnnual report
「As of the end of the month preceding the filing date, potential shares represented by stock acquisition rights were 14,376,000 shares, equivalent to 33.7% of the total number of shares issued, 42,698,920 shares (as of 31 May 2026).」
The disclosure states that potential shares represented by stock acquisition rights reached 14,376,000, or 33.7% of the total number of shares issued, quantifying the potential for substantial dilution. - FY2026-H1MaterialisedAnnual report
「1 September 2025–30 September 2025 134,000 3,282,992 67,312 1,118,394 67,312 1,060,021 Other increases through the exercise of stock acquisition rights.」
The issuance of 500,000 new shares through a third-party allotment and an increase of 134,000 shares through the exercise of stock acquisition rights occurred. The increase in shares that could lead to dilution has continued. - FY2024MaterialisedAnnual report
「As of the end of the month preceding the filing date, potential shares represented by stock acquisition rights were 197,800 shares, equivalent to 7.4% of the total number of shares issued, 2,648,992 shares (as of 31 May 2024).」
Potential shares represented by stock acquisition rights were 197,800, equivalent to 7.4% of the total number of shares issued. The number of shares increased by 41,800 through the exercise of stock acquisition rights during the fiscal year. - FY2024-Q2MaterialisedAnnual report
「25 July 2023 (Note) 2 1,000 2,648,992 600 915,331 600 856,958 (Note) 2. Increase through the exercise of stock acquisition rights.」
On 25 July 2023, the number of shares increased by 1,000 through the exercise of stock acquisition rights, bringing the total number of shares issued to 2,648,992. - FY2024-Q1MaterialisedAnnual report
「1 April 2023–30 June 2023 (Note) 1 40,800 2,632,859 22,431 899,734 22,431 841,361 (Note) 1. Increase through the exercise of stock acquisition rights. As the issuance of new shares through the exercise of the ninth series of stock acquisition rights on 25 July 2023, the number of shares issued as of the filing date increased by 1,000 shares.」
During the first quarter, the number of shares increased by 40,800 through the exercise of stock acquisition rights, followed by a further increase of 1,000 shares before the filing date. The issuance of shares that could lead to dilution has continued. - FY2023MaterialisedAnnual report
「As of the end of the month preceding the filing date, potential shares represented by stock acquisition rights were 200,500 shares, equivalent to 7.6% of the total number of shares issued, 2,632,859 shares (as of 31 May 2023).」
During the fiscal year, the number of shares increased by 192,300 through the exercise of stock acquisition rights, while potential shares were 200,500, equivalent to 7.6% of the total number of shares issued. - FY2023-Q3MaterialisedAnnual report
「1 October 2022–31 December 2022 (Note) 114,200 2,517,059 62,787 836,067 62,787 777,694 (Note) Increase through the exercise of stock acquisition rights.」
During the third-quarter accounting period, the total number of shares issued increased by 114,200 shares through the exercise of stock acquisition rights, bringing the total to 2,517,059 shares. The increase in shares that could lead to dilution continued to occur. - FY2023-Q1MaterialisedAnnual report
「Note: The increase resulted from the exercise of stock acquisition rights.」
During the first quarter, the total number of shares issued increased by 3,100 shares through the exercise of stock acquisition rights. In addition, stock acquisition rights for 107,000 common shares were issued as the 11th series of stock acquisition rights, updating a potential source of share dilution. - FY2022MaterialisedAnnual report
「As of the end of the month preceding the filing date, potential shares represented by stock acquisition rights were 448,500 shares, equivalent to 18.7% of the total number of shares issued, 2,396,234 shares (as of 31 May 2022).」
The issuance of shares through the exercise of stock acquisition rights increased the number of shares by 63,000 during the fiscal year, while potential shares at the end of the month preceding the filing date were 448,500, equivalent to 18.7% of the total number of shares issued. - FY2022-Q1MaterialisedAnnual report
「1 April 2021–30 June 2021 (Note) 63,000 2,393,183 22,400 768,243 21,105 709,870 (Note) Increase through the exercise of stock acquisition rights.」
During the cumulative first-quarter period, the total number of shares issued increased by 63,000 shares through the exercise of stock acquisition rights, and potential dilution continued to occur. - FY2021MaterialisedAnnual report
「1 April 2020–31 March 2021 11,900 shares Increase through the exercise of stock acquisition rights」
During the fiscal year, the total number of shares issued increased by 11,900 shares through the exercise of stock acquisition rights. As of the end of the month preceding the filing date, potential shares were 118,600, equivalent to 4.9% of the total number of shares issued. - FY2021-Q2MaterialisedAnnual report
「Funds provided by financing activities amounted to ¥7.973 million (compared with ¥8.052 million used in the same quarter of the previous year). This was due to proceeds of ¥7.973 million from the issuance of shares through the exercise of stock acquisition rights.」
Proceeds of ¥7.973 million from the issuance of shares through the exercise of stock acquisition rights were recorded, and potential dilution continued to occur. - FY2021-Q1MaterialisedAnnual report
「1 April 2020–30 June 2020 11,900 shares Increase through the exercise of stock acquisition rights」
During the cumulative first-quarter period, the total number of shares issued increased by 11,900 shares through the exercise of stock acquisition rights, and potential dilution continued to occur. - FY2020MaterialisedAnnual report
「1 April 2019–31 March 2020 6,500 shares Increase through the exercise of stock acquisition rights (stock options)」
During the fiscal year, the total number of shares issued increased by 6,500 shares through the exercise of stock acquisition rights. As of the end of the month preceding the filing date, potential shares were 226,000, equivalent to 9.8% of the total number of shares issued, 2,313,500 shares. - FY2020-Q3MaterialisedAnnual report
「This was mainly because capital stock increased by ¥3.741 million and capital surplus increased by ¥3.741 million in connection with payments received upon the exercise of stock acquisition rights.」
The disclosure states that capital stock and capital surplus each increased by ¥3.741 million in connection with payments received upon the exercise of stock acquisition rights. - FY2020-Q2MaterialisedAnnual report
「1 July 2019–30 September 2019 (Note) 5,800 2,312,500 3,321 737,857 3,321 680,779 (Note) Increase through the exercise of stock acquisition rights.」
During the second-quarter accounting period, the total number of shares issued increased by 5,800 shares through the exercise of stock acquisition rights, and potential dilution continued to occur. - FY2020-Q1MaterialisedAnnual report
「1 April 2019–30 June 2019 700 shares Increase through the exercise of stock acquisition rights」
During the cumulative first-quarter period, the total number of shares issued increased by 700 shares through the exercise of stock acquisition rights, and potential dilution continued to occur. - FY2019MaterialisedAnnual report
「1 April 2018–31 March 2019 3,100 shares Increase through the exercise of stock acquisition rights (stock options)」
During the fiscal year, the total number of shares issued increased by 3,100 shares through the exercise of stock acquisition rights. As of the end of the month preceding the filing date, potential shares were 234,100, equivalent to 10.1% of the total number of shares issued. - FY2019-Q2MaterialisedAnnual report
「(Note) Increase resulting from the exercise of stock acquisition rights.」
Between 1 July and 30 September 2018, the total number of shares issued increased by 3,100 shares through the exercise of stock acquisition rights, and potential dilution continued to occur. - FY2019-Q1MaterialisedAnnual report
「Between 1 July 2018 and 31 July 2018, the total number of shares issued increased by 800 shares through the exercise of stock acquisition rights.」
The total number of shares issued increased by 800 shares through the exercise of stock acquisition rights, creating a potential source of dilution. - FY2018First statedAnnual report
「As of the filing date, potential shares represented by stock acquisition rights were 249,500 shares, equivalent to 10.8% of the total number of shares issued, 2,302,900 shares (as of 28 June 2018).」
The potential dilution from the exercise of stock acquisition rights was quantified as 249,500 potential shares, or 10.8% of the total number of shares issued.